Exam Details
Subject | pharmacoepidmiology and pharmacoeconomics | |
Paper | ||
Exam / Course | pharm d (6–ydc) | |
Department | ||
Organization | G. Pulla Reddy College Of Pharmacy | |
Position | ||
Exam Date | January, 2018 | |
City, State | telangana, hyderabad |
Question Paper
FACULTY OF PHARMACY
Pharm. D. YDC) V-Year (Instant) Examination, January 2018
Subject: Pharmaco epidemiology and Pharmacoeconomics
Time: 3 Hours Max.Marks: 70
Note: Answer all questions from Part A. Answer any five questions from Part B.
PART A (10 x 2 20 Marks)
1 Define cost utility analysis. 2
2 What do you mean by cost effectiveness analysis? 2
3 What do you mean prescription event monitoring? 2
4 Define formulary. 2
5 Mention pharmacoeconomic principles. 2
6 Write short notes on: 2
Case report
ii) Case series.
7 Write a note on meta analysis. 2
8 Mention two applications of pharmacoeconomics. 2
9 Write a note on spontaneous reporting. 2
10 What do you mean by decision analysis? 2
PART B x 10 50 Marks)
11 Describe in detail need and applications of pharmacoeconomics and
pharmacoepidemiological studies in the field of pharmacy practice. 10
12 Write notes on attributable risk, relative risk and odds ratio. 10
13 Describe in detail, theoretical pharmacoepidemiological methods with the help of
case studies. 10
14 Write notes on Adhoc data source and automated data system. 10
15 Explain in detail developing a formulary list and formulary management. 7
Short note on teratology reports. 3
16 Explain in detail cost minimization, cost benefit and cost effectiveness analysis
with the help of case studies. 10
17 Explain health economics, health outcome research and health related quality of
life. 10
18 Write short note on DDD, PDD and medication adherence measurement. 10
Pharm. D. YDC) V-Year (Instant) Examination, January 2018
Subject: Pharmaco epidemiology and Pharmacoeconomics
Time: 3 Hours Max.Marks: 70
Note: Answer all questions from Part A. Answer any five questions from Part B.
PART A (10 x 2 20 Marks)
1 Define cost utility analysis. 2
2 What do you mean by cost effectiveness analysis? 2
3 What do you mean prescription event monitoring? 2
4 Define formulary. 2
5 Mention pharmacoeconomic principles. 2
6 Write short notes on: 2
Case report
ii) Case series.
7 Write a note on meta analysis. 2
8 Mention two applications of pharmacoeconomics. 2
9 Write a note on spontaneous reporting. 2
10 What do you mean by decision analysis? 2
PART B x 10 50 Marks)
11 Describe in detail need and applications of pharmacoeconomics and
pharmacoepidemiological studies in the field of pharmacy practice. 10
12 Write notes on attributable risk, relative risk and odds ratio. 10
13 Describe in detail, theoretical pharmacoepidemiological methods with the help of
case studies. 10
14 Write notes on Adhoc data source and automated data system. 10
15 Explain in detail developing a formulary list and formulary management. 7
Short note on teratology reports. 3
16 Explain in detail cost minimization, cost benefit and cost effectiveness analysis
with the help of case studies. 10
17 Explain health economics, health outcome research and health related quality of
life. 10
18 Write short note on DDD, PDD and medication adherence measurement. 10
Other Question Papers
Subjects
- biology
- biopharmaceutics & pharmacokinetics
- biostatistics & research methodology
- clinical & pharmacokinetics pharmacotherapeutic drug monitoring
- clinical pharmacokinetics and pharmacotherapeutic drug monitoring
- clinical pharmacy
- clinical research
- clinical toxicology
- community pharmacy
- hospital pharmacy
- human anatomy and physiology
- medicinal biochemistry
- medicinal chemistry
- pathophysiology
- pharmaceutical analysis
- pharmaceutical formulations
- pharmaceutical inorganic chemistry
- pharmaceutical jurisprudence
- pharmaceutical microbiology
- pharmaceutical organic chemistry
- pharmaceutics
- pharmacoepidmiology and pharmacoeconomics
- pharmacognosy & phytopharmaceuticals
- pharmacology – i
- pharmacology – ii
- pharmacotherapeutics – i
- pharmacotherapeutics – iii
- pharmacotherapeutics-ii